Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Nanox scores FDA clearance for single-source X-ray technology

The Israel-based startup has been working for months to obtain the regulatory greenlight for its new approach to legacy imaging.

Nanox

Nanox earns FDA clearance for its novel digital X-ray machine

Chairman and CEO Ran Poliakine called the news a "significant step forward" for the Israeli company's U.S. regulatory pathway.

Thumbnail

Fast breast MRI ready for clinical use following shorter read times, accurate cancer detection

Abbreviated MRI protocols not only shorten exam times but may significantly reduce costs and improve breast cancer screening overall.

Thumbnail

New guide helps clinicians better diagnose coronary artery disease using PET myocardial blood flow

SNMMI and ASNC developed their step-by-step document to be a somewhat easy read, sharing the 20-page statement free online.

interventional radiology philips

Radiology, other multispecialty groups urge caution with GBCAs during interventional pain procedures

A group of 11 societies issued a practice advisory recently to help physicians better select contrast agents and manage adverse events.

Imaging COVID-19 a year later: Recovery is possible even in severe cases

A pair of radiologists detailed the case of a 55-year-old woman diagnosed with severe illness back in February 2020.

vaccine syringe covid-19 coronavirus

Molecular imaging group shares updates for managing COVID-19 vaccine effects on PET/CT exams

Lymph node swelling has been reported in up to 16% of patients who've received either the Pfizer/BioNTech or Moderna shots, SNMMI noted.

Thumbnail

Ultrasound maker Butterfly Network’s stock slides after first earnings report, despite revenue surge

The Connecticut-based imaging firm is eyeing further growth after just completing its $1.5B merger with an affiliate of Glenview Capital Management.